“Efficacy and Safety of Apremilast in Patients With Genital Psoriasis: Results From the Phase 3, Randomized, Placebo-Controlled, Double-blind DISCREET Study” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s110. doi:10.25251/skin.7.supp.110.